CD44 and urinary bladder carcinoma: Data from five studies included 197 patients with bladder cancer and 69 non-tumor tissue samples, which showed that CD44 expression was lower in bladder cancer than in non-tumor tissue samples (OR = 0.14, 95% CI = 0.04–0.54, P = 0.005) (Figure 2).